An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease (Q63811743)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease |
clinical trial |
Statements
A PHASE 3, MULTI CENTER, OPEN-LABEL EXTENSION STUDY OF ORAL OZANIMOD FOR MODERATELY TO SEVERLY ACTIVE CROHN's DISEASE (English)
0 references
22 August 2018
0 references
30 December 2022
0 references
1,200
0 references
18 year
0 references
75 year
0 references